Insider holders · CIK 0001728328
InMed Pharmaceuticals Inc. · INM
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC10% Owner | — | 892,101 | 892,101 | Sep 16, 2026 · 6:58 pm EDT | Form 4 |
| Daniel Schneeberger10% Owner | — | 892,101 | 892,101 | Sep 16, 2026 · 6:58 pm EDT | Form 4 |
| Vivo Opportunity Fund Holdings, L.P.10% Owner | — | 75,019 | 75,019 | Jul 16, 2026 · 9:58 pm EDT | Form 4 |
| Vivo Opportunity Cayman, LLC10% Owner | — | 75,019 | 75,019 | Jul 16, 2026 · 9:58 pm EDT | Form 4 |
| Vivo Opportunity Cayman Fund, L.P.10% Owner | — | 75,019 | 75,019 | Jul 16, 2026 · 9:58 pm EDT | Form 4 |
| Vivo Opportunity, LLC10% Owner | — | 75,019 | 75,019 | Jul 16, 2026 · 9:58 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.